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 Age-related macular degeneration (AMD) is a leading
cause of blindness in the elderly population of industrialized
countries [1]. Although several therapies including photody-
namic therapy [2] and anti-VEGF therapy [3] have been re-
cently developed, they can only stabilize the already reduced
vision. An incomplete understanding of the pathogenesis of
AMD may be one reason for the limited success of the thera-
pies currently used [4,5].
AMD is characterized by a progressive degeneration of
the neurosensory retina, retinal pigment epithelium (RPE), and
choriocapillaris in the macular area. Because the macula, which
is subjected to the highest levels of cumulative irradiation,
has the highest level of oxygen consumption and has a unique
composition of fatty acids [6], oxidative stress has been sug-
gested to be part of the initial pathogenic mechanism of AMD
[7-9].
In vitro studies have shown that feeding oxidized photo-
receptor outer segments to cultured RPE cells increased the
number of lipofuscin granules in the RPE cells [10]. Excess
accumulation of lipofuscin and lysosomes in RPE cells can
lead to drusen formation, an initial clinical change in AMD
[11]. However, a direct relationship between the oxidative
changes and the development of AMD has not been reported.
In a histopathological study, Curcio and co-workers dem-
onstrated an age-related accumulation of cholesterol esters in
Bruch’s membrane similar to that observed in the arterial in-
tima [12]. Killingsworth et al. also observed that macroph-
ages and phospholipid-containing debris were co-localized in
Bruch’s membrane in eyes with AMD [13]. Because these
pathological changes in AMD are similar to those seen in ath-
erosclerosis [12-17], and because atherosclerotic changes may
contribute to the pathogenesis of AMD [18,19], we hypoth-
esized that oxidized phospholipids would accumulate in the
eyes of patients with AMD as has been demonstrated in the
arteries of patients with atherosclerosis [20]. The presence of
oxidized phospholipids in the macula region has not been re-
ported, so we first investigated whether they were present in
normal eyes and whether the level changed with increasing
age. Then, we determined whether oxidized phospholipids
were increased in eyes with AMD to test our hypothesis.
METHODS
Reagents:  All chemicals, unless otherwise stated, were pur-
chased from Vector Laboratories (Burlingame, CA). A mono-
clonal IgM antibody against oxidized low-density lipoprotein
(LDL), FOH1a/DLH3, that specifically recognizes oxidized
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772phosphatidylcholine (Ox-PC) was generated in one of the
coauthor’s laboratory by immunizing a mouse against
homogenates of human atheroma [21].
Donor tissues:  Twenty normal human donor eyes and
six eyes with AMD were used. The normal eyes were obtained
from the Cleveland Eye Bank (Cleveland, OH) or the National
Disease Research Interchange (Philadelphia, PA). The AMD
donor eyes were obtained from patients clinically diagnosed
with AMD, and the donors were registered through the Eye
Donor Program of The Foundation Fighting Blindness (Hunt
Valley, MD). Eyes were frozen in liquid nitrogen after enucle-
ation.
Tissue preparation:  A 10x12 mm rectangular section was
cut from the posterior pole or the periphery of each frozen or
fixed globe according to a described method described by Itabe,
et al. [5].
A 2 mm-wide strip of the retina-RPE-choroid-sclera com-
plex, centered on the fovea, was dissected from the section. It
was embedded in optimum cutting temperature (OCT) com-
pound (Sakura Finetechnical Co, Ltd, Tokyo, Japan), and 8
µm thick cryosections were cut for immunohistochemistry.
The remaining tissue was used for western blot analysis and
other experiments.
Immunohistochemistry:  Indirect immunohistochemistry
was performed on cryosections of the human tissue using the
avidin-biotin complex immunoperoxidase technique. Briefly,
after fixing the sections in cold 4% formaldehyde, the endog-
enous peroxidase activity was blocked by NaIO4. The speci-
mens were incubated with 5% bovine serum albumin (BSA)
in phosphate buffered saline (PBS) to block nonspecific
immunoreaction and then exposed to a monoclonal antibody
against oxidized phospholipids, DLH3 [21], at a dilution of
1:100 followed by incubation with a biotinylated horse anti-
mouse IgM antibody. The sections were then incubated with
streptoavidin-biotin complex labeled with peroxidase. The
immunoreactivity was made visible by 3-amino-9-
ethylcarbazole (AEC, Vector Laboratories). Sections incubated
with nonimmune mouse IgM as a primary antibody served as
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Figure 1. Immunohistochemical examination for oxidized phospholipids of a normal eye.  A: Retinal section from the macula area of a normal
eye. Negative control with non-immunized mouse IgM as a primary antibody. Original magnification, x100. Scale bar represents 50 µm. B:
Retinal section from the macula area of a normal eye. Oxidized phospholipids are detected in the inner and outer retina and choroid. Original
magnification, x100. Scale bar represents 50 µm. C: Retinal section from the macula area of a normal eye. Oxidized phospholipids are seen
mostly in the photoreceptors (PS) and retinal pigment epithelium (RPE). Immunohistochemical analysis of the photoreceptor inner and outer
segments demonstrated diffuse immunoreactivity (arrowheads). Both the basal and apical sides of the RPE cells are primarily stained (ar-
rows). Original magnification, x600. Scale bar represents 50 µm. D: Retinal section from the peripheral area of a normal eye. Oxidized
phospholipids are seen in the photoreceptor inner and outer segments (arrows). Immunoreactivity was less intense than in the macular area.
Original magnification, x600. Scale bar represents 50 µm. ONL indicates outer nuclear layer
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Figure 2. Increased oxidized phospholipids immunostaining with
advancing age in normal eyes.  Sections were from the following:
(A) 38-year-old donor; (B) 57-year-old donor; (C) 65-year-old do-
nor; and (D) 76-year-old donor. Original magnification, x600. Scale
bar represents 50 µm. The eyes from the younger donors, especially
the 38-year-old donor, is immunostained much less than the older
eyes. E: Threshold values of immunoreactivity for oxidized phos-
pholipids in the photoreceptors. F: Percentage area of field
immunostained for oxidized phospholipids in the retinal pigment
epithelium (RPE). ONL indicates outer nuclear layer, and PS repre-
sents photoreceptors.
774negative controls. Three serial sections of each eye were ana-
lyzed, and the examiners were masked to the age of the eyes.
For quantitative immunohistochemical analysis, the den-
sity of the staining in the photoreceptors and the
immunostained area in the RPE was measured with the NIH
image software based on the threshold technique. The corre-
lations between the age and the density of staining were deter-
mined with the Spearman rank correlation coefficient. Differ-
ences between AMD and age-matched normal tissue were
analyzed with the Mann-Whitney test.
Western blot analysis:  To examine which molecules were
recognized by DLH3, we performed western blot analysis with
the retinal lysates from normal donor eyes. Proteins were ob-
tained for the western blots from a 10x10-mm wide square of
retina from each donor eye. Tissues were lysed in a 10 fold
volume of extraction buffer (200 mM NaCl, 1% Triton X-
100, 500 mM Tris-Hcl, pH 7.6) using a sonicator (four bursts
of 5 s). After centrifugation at 15 000 rpm for 15 min, the
supernatant was collected. The protein concentration of each
sample was measured using bicinchoninic acid (BCA; Pierce,
Rockford, IL) and BSA as a reference standard.
Then 25 µg of total protein was carefully measured out,
boiled in SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 25%
glycerol, 0.01% bromophenol blue, and 2% SDS), separated
by SDS-PAGE, and transferred to Immobilon-P membranes
(Millipore, Bedford, MA) using a Bio-Rad Semi-Dry Elec-
trophoretic Transfer Cell (20 min transfer at 18 volts). After
the transfer, the membranes were blocked with 2% BSA in
PBS for 1 h at room temperature, and the gels were stained
with Gelcode (Pierce) to determine the isolated proteins.
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Figure 3. Oxidized lipoprotein immunostaining is more intense in
eyes with age-related macular degeneration than in age-matched
normal eyes.  A: Photoreceptors (PS) of 75-year-old normal do-
nor. B: PS of 70-year-old age related macular degeneration (AMD)
donor, C: Retinal pigment epithelium (RPE) of the same normal
donor as A. D: RPE of the same AMD donor as B. Eyes with
AMD show more intense immunoreactivity for oxidized phos-
pholipids than age-matched normal eyes in both the photorecep-
tors and RPE cells. In the AMD eyes, note that the areas with
continuous soft drusen show immunoreactivity (arrowheads).
Original magnification, x600. Scale bar represents 50 µm. E: Mean
threshold values of immunoreactivity for oxidized phospholipids
in the photoreceptors of non-AMD age-matched control donor eyes
(clear column) and AMD (filled column). F: Mean percentage area
of field immunostained for oxidized phospholipids in the RPE of
non-AMD age-matched control donor eyes (clear column) and
AMD (filled column).
775The membranes were then incubated with the primary
antibody for Ox-PC, DLH3, at 1:1000 dilution overnight at 4
°C. The membranes were washed with 0.05% Tween in PBS
and then incubated with Alexa Fluor® 568 goat anti-mouse
IgM in 0.05% PBS/Tween for 1 h at room temperature. The
western blot was imaged with Typhoon 8600 (GE Healthcare
Bio-Sciences Corp., Piscataway, NJ) using a 532 nm excita-
tion filter. The images were displayed using the Image Quant™
software (GE Healthcare Bio-Sciences Corp). The densities
of the bands were quantified with the NIH image software.
The correlations between the age and densities were deter-
mined with the Spearman rank correlation coefficient.
RESULTS
Immunohistochemistry:  Positive staining for oxidized phos-
pholipids was observed in the photoreceptor inner and outer
segments and RPE cells in normal human donor eyes (Figure
1). Immunoreactivity in the photoreceptor inner and outer seg-
ments in the macular area was higher than in the peripheral
area. Both the basal and the apical sides of the RPE cells were
primarily stained. There was no difference between fixed and
frozen globes in the stain pattern with this antibody.
A comparison of the immunoreactivity of eyes of differ-
ent ages showed that eyes from younger donors (under 60
years) showed less intense immunoreactivity than eyes from
older donors (60 years or older) in both the photoreceptors
and RPE cells (Figure 2A-D). The immunological staining
density was significantly correlated with age in the photore-
ceptors (r=0.8911; n=16; p<0.01; Spearman rank correlation
coefficient; Figure 2E) and RPE (r=0.9283; n=20; p<0.01;
Spearman rank correlation coefficient; Figure 2F). Oxidized
phospholipids in the photoreceptors were analyzed in only 16
normal eyes, because the photoreceptors of the remaining four
eyes were not well-preserved.
Eyes with AMD showed more intense immunoreactivity
than that in age-matched normal eyes. Immunostaining was
more prominent in the RPE cells than in the photoreceptors
(Figure 3). The soft drusen in the AMD eyes were also
immunopositive for oxidized phospholipids, which suggested
that the oxidized compounds may be more difficult to digest
by the lysosomes in the RPE cells and were exocytosed to
Bruch’s membrane. The staining intensity in the photorecep-
tors was higher in AMD eyes than in age-matched normal eyes
(p<0.01; n=6; Mann-Whitney test; Figure 3E). The
immunostained areas were stained more strongly in AMD eyes
than in age-matched normal eyes (p<0.01; n=6; Mann-Whitney
test; Figure 3F).
Western blot analysis:  Western blot analysis showed sev-
eral bands that might represent molecules containing oxidized
phosphatidylcholines just as atherosclerosis lipoproteins show
several bands or smear-staining [22]. The density of the bands
increased with age (r=0.8928; n=7; p<0.01; Spearman rank
correlation coefficient; Figure 4B). The phospholipids that
formed the plasma membrane exist partly as lipoproteins, a
complex of phospholipids and proteins. Phospholipids, includ-
ing phosphatidylcholine, can immunoreact with FOH1a/DLH3
when the phosphatidylcholines are oxidized, because DLH3
recognizes oxidized phosphatidylcholines.
DISCUSSION
 Although strong evidence has accumulated that oxidative
stress plays a key role in the pathogenesis of AMD [4,7-9], it
has not been directly demonstrated how the oxidative stress
contributes to the development and progression of the disease.
For example, it has not been established whether oxidized
materials are present in the appropriate areas of eyes with
AMD. Our results confirmed that oxidized phospholipids were
indeed present in the photoreceptors and RPE cells in the
macula region of the normal eyes, and the quantity increased
with age. In addition, eyes with AMD showed more intense
immunoreactivity to oxidized phospholipids than age-matched
normal eyes. These results support our hypothesis that oxi-
dized phospholipids accumulate in the eyes of patients with
AMD. These findings would then indicate that oxidative dam-
age of the photoreceptors and RPE cells may be the mecha-
nism for the changes induced in eyes with AMD. We suggest
that the oxidation of phospholipids in the photoreceptors may
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Figure 4. Comparison of the level of the oxidized phospholipids us-
ing Western blot analysis with 25 µg of proteins of the samples from
normal donor eyes of different ages.  A: Several bands that probably
represent phospholipids containing oxidized phosphatidylcholines can
be seen. The intensity of the bands increases with age. Lane 1 is the:
molecular weight marker, lanes 2-8: samples from donors aged 17,
20, 35, 68, 74, 83, and 98 years old, respectively. B: Densitometric
measurements of the FOH1a/DLH3 immunoreactivity. A significant
correlation can be seen between age and the density of staining
(r=0.89).
776lead to incomplete digestion of the photoreceptor discs ph-
agocytosed by the RPE. This may result in the accumulation
of lipofuscin in the RPE and subsequently drusen formation.
Finally, the accumulation of lipofuscin could lead to RPE dys-
function, which would then cause the death of photoreceptor
cells.
The degree of positive immunoreactivity in the photore-
ceptor inner and outer segments in the macular area was higher
than in the peripheral area. The photoreceptors are probably
subject to oxidative modifications because of their unique
structure. The outer segments consist of continuous infoldings
of the plasma membrane, which means that the photorecep-
tors contain much more phospholipids, which include high
polyunsaturated fatty acids that are subject to oxidative modi-
fications, than other cells of the retina [6]. Additionally in the
macular area, the level of oxygen from the choroidal circula-
tion could be higher [23] because photoreceptor density is
higher than the periphery [24]. The results of a study also
showed that the level of oxidized LDL in the plasma is in-
creased in patients with AMD possibly in relation to
paraoxonase gene polymorphisms [25].
Considering that AMD is a disease affecting the photore-
ceptors, RPE cells, and choriocapillaris, it is interesting that
oxidized phospholipids were detected almost exclusively in
the photoreceptors and RPE cells and were not observed in
the inner layers of the retina. RPE cells continuously ingest
shed photoreceptor discs at their apical border, form
phagosomes within the cytoplasm, breakdown the fragments
of the outer segment discs in their lysosomes, and exocytose
the degraded materials on the basal side. Because an accumu-
lation of oxidized compounds inhibits the function of
phagosomes in the RPE [26,27], incompletely digested pho-
toreceptors containing oxidized phospholipids are probably
exocytosed and observed as debris. This is consistent with our
results that oxidized phospholipids were found in the RPE cells
and in soft drusen. Our findings confirm and expand the re-
sults of previous studies reporting that lipoproteins and phos-
pholipids are contained in drusen [28,29], and that oxidation
of these materials is strongly related to AMD [7,8].
We are not aware of any published study that has demon-
strated the presence of oxidized phospholipids in the macula,
probably because an antibody to detect oxidized phospholip-
ids has not been commercially available. The antibody we
employed recognizes oxidized phosphatidylcholines [30], and
has been used to detect oxidized LDL by immunohistochem-
istry and ELISA [31,32]. The phosphatidylcholines are one of
the most abundant phospholipids in the photoreceptors and
account for approximately one-third of the total lipids in the
photoreceptors [25]. We tried sandwich ELISA with DLH3
and anti-apoB antibodies to quantify the oxidized lipoproteins
in the retina, but we could not obtain reliable results probably
because apoB does not exist in the photoreceptors. Establish-
ing a quantitative method to evaluate the amount of oxidized
phospholipids in the retina remains as a challenge for the fu-
ture.
In the early stage of atherosclerosis, endocytosis of oxi-
dized LDL including oxidized phospholipids by macrophages
and subsequent foam cell transformation are key events [33].
Because macrophages also accumulate in the AMD lesions
[14,34], and the presence of oxidized phospholipids in AMD
lesions have been shown in this study, macrophages may take
up oxidized phospholipids as observed in atherosclerosis. We
are investigating whether macrophages in AMD lesions ex-
press scavenger receptors for oxidized phospholipids.
In conclusion, our results demonstrated that oxidized phos-
pholipids were present in the normal human macular region,
and their levels increase with age as in the arterial intima in
atherosclerosis. In addition, eyes with AMD have more in-
tense immunoreactivity for oxidized phospholipids than age-
matched normal eyes. These findings indicate that oxidative
stress is probably involved in the pathogenesis of AMD. Our
findings are consistent with the suggestion that supplementa-
tion with antioxidants, vitamins, and minerals may reduce the
risk of developing AMD [35].
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